Integrating technology into adolescent care

Practical Diabetes

Volumn 29, Issue 5, 2012, Pages 201-204a

  Lamb, W H ^a  

^a Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

Author keywords

Adolescence; Communication; Data analysis; Glucose sensors; Insulin pumps; Technology

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; KETONE;

BEHAVIOR THERAPY; BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETIC KETOACIDOSIS; EARLY DIAGNOSIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERNET; JUVENILE; METABOLISM; REVIEW; SKILL; TECHNOLOGY; TELECONSULTATION; TREATMENT RESPONSE;

EID: 84863658454     PISSN: None     EISSN: 20472900     Source Type: Journal    
DOI: 10.1002/pdi.1690     Document Type: Review

References (39)

1. Shakespeare W. The Winter's Tale. III: iii: 59-62.
2. Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2, 873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes. Diabetes Care 1997;20:714-20. (Pubitemid 27202518)
3. Lamb W. Unpublished audit data 1989-2011. Bishop Auckland Children's Diabetes Service 2012.
4. Amiel SA, et al. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986;315:215-9. (Pubitemid 16097122)
5. Casey BJ, Jones RM. Neurobiology of the adolescent brain and behavior: implications for substance use disorders. J Am Acad Child Adolesc Psychiatry 2010;49:1189-201.
6. Steinberg S, Morris AS. Adolescent development. Annu Rev Psychol 2001;52:83-110. (Pubitemid 33705568)
7. Anderson B, et al. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997;130:257-65. (Pubitemid 27495162)
8. Waylen A, Wolke D. Sex 'n' drugs 'n' rock 'n' roll: the meaning and social consequences of pubertal timing. Eur J Endocrinol 2004;151:151-9.
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
10. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177-88.
11. Alam R, et al. An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and general clinicians on glycaemic control and on psychological status. Patient Educ Couns 2009;75:25-36.
12. Sutcliffe P, et al. Systematic review of communication technologies to promote access and engagement of young people with diabetes into health care. BMC Endocr Disord 2011;11:1.
13. Russel-Minda E, et al. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol 2009;3:1460-71.
14. Franklin VL, et al. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med 2006;23:1332-8. (Pubitemid 44787797)
15. Franklin VL, et al. "Sweet Talk": text messaging support for intensive insulin therapy for young people with diabetes. Diabetes Technol Ther 2003;5:991-6.
16. Lehmkuhl HD, et al. Telehealth behavior therapy for the management of type 1 diabetes in adolescents. J Diabetes Sci Technol 2010;4:199-208.
17. Vesco AT, et al. Responsibility sharing between adolescents with type 1 diabetes and their caregivers: importance of adolescent perceptions on diabetes management and control. J Pediatr Psychol 2010;35:1168-77.
18. Farrell K, Holmes-Walker D. Mobile phone support is associated with reduced ketoacidosis in young adults. Diabet Med 2011;28; 1001-4.
19. Mulvaney SA, et al. An internet-based program to improve self-management in adolescents with type 1 diabetes. Diabetes Care 2010;33:602-4.
20. Ziegler R, et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 2011;12:11-7.
21. Guilfoyle SM, et al. Blood glucose monitoring and glycemic control in adolescents with type 1 diabetes: meter downloads versus self-report. Pediatr Diabetes 2011;12:560-6.
22. Laffel LM, et al. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med 2006;23:278-84.
23. Bismuth E, Laffel L. Can we prevent diabetic ketoacidosis in children? Pediatr Diabetes 2007;8(Suppl 6):24-33. (Pubitemid 47323764)
24. Noyes KJ, et al. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes 2007;8:150-6. (Pubitemid 46864296)
25. Barnard K, et al. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections. J Diabetes Sci Technol 2012;6:144-9.
26. ®: one device to read them all and in the clinic guide them. Endocrine Abstracts 2008;17:48.
27. Tamborlane WV, et al. Reduction to normal of plasma glucose in juvenile diabetes by sub cutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979;15;300:573-8.
28. de Bock M, et al. Impact of insulin pumps on glycaemic control in a pump-naïve paediatric regional population. J Paediatr Child Health 2011;48:247-52.
29. Wood JR, et al. Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care 2006;29:2355-60. (Pubitemid 44912235)
30. Gane J, et al. Systematic review and meta-analysis of insulin pump therapy in children and adolescents with type 1 diabetes. Arch Dis Childhood 2010;95:A94.
31. Cummins E, et al. Clinical effectiveness and costeffectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 2010;14(11):iii-iv, xi-xvi, 1-181.
32. Olinder AL, et al. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatr Diabetes 2009;10:142-8.
33. O'Connell MA, et al. Poor adherence to integral daily tasks limits the efficacy of CSII in youth. Pediatr Diabetes 2011;12:556-9.
34. Olinder AL, et al. Reasons for missed meal-time insulin boluses from the perspective of adolescents using insulin pumps: 'lost focus'. Pediatr Diabetes 2011;12:402-9.
35. Lamb WH. Unpublished insulin pump audit data; 2003-2012. Bishop Auckland Children's Diabetes Service 2012.
36. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-76.
37. Slover RH, et al. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes 2012;13:6-11.
38. Keymeulen B, et al. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 2010;53:614-23.
39. Hovorka R, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-51.